Información:
Error:
ID
34154
Descripción
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32; ODM derived from: https://clinicaltrials.gov/show/NCT01286233
Link
https://clinicaltrials.gov/show/NCT01286233
Palabras clave
Versiones (1)
- 14/1/19 14/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
14 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Breast Cancer NCT01286233
Eligibility Breast Cancer NCT01286233
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01286233
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
the patient must have consented to participate and must have signed and dated an appropriate irb-approved consent form that conforms to federal and institutional guidelines for the ma.32.f study before being enrolled.
boolean
ID.2
Item
the patient must be female.
boolean
ID.3
Item
the patient must reside in the united states or canada.
boolean
ID.4
Item
the patient must be english-speaking.
boolean
ID.5
Item
the patient must be eligible for randomization in the ma.32 treatment trial. (participation in the ma.32 qol study is permitted but not required.)
boolean
ID.6
Item
the patient must not have started taking ma.32 study therapy.
boolean
ID.7
Item
the patient must have completed primary breast radiation therapy at least two weeks prior to enrollment in ma.32.f.
boolean
ID.8
Item
ma.32 study therapy has been initiated.
boolean
ID.9
Item
currently receiving radiation therapy or additional radiation therapy is planned for initiation after starting ma.32 study therapy.
boolean